They were recruited if they were older than 18 years and had advanced liver cirrhosis, Child B or C, confirmed by ultrasound and/or biopsy. Main exclusion criteria were malignant comorbidity ...

In summary, the study shows that fatty liver is very common in people with type 2 diabetes, especially when obesity is also ...

Discover a study where results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver ...

Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

The researchers performed ultrasound evaluations ... requires surgery to treat. Cirrhosis can be the result of chronic alcohol consumption, hepatitis, or other liver-related conditions.

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...

In patients with cirrhosis, especially those in the advanced stage who have decompensation ... the use of MARS for patients with acute-on-chronic liver failure showed an improvement in hepatic ...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...

The goals of nutritional therapy are to improve PCM and correct nutrient deficiencies. This can be accomplished via oral, enteral, or parenteral methods, or a combination of these modalities ...